| New antiretroviral targets and compounds, mechanisms of drug resistance |
WePp01 | |
| Type: |
Poster Presentations |
| Venue: |
Poster presentation area |
| Time: |
12:30 - 13:45 |
| Chairperson: |
Ricardo Sobhie Diaz, Brazil |
|
Presentations in this session:
12:35
WePp0102
Abstract
|
The L74V mutation in HIV-1 RT impairs unblocking of ZDV-terminated DNA primers and reduces synthesis of viral DNA in real-time PCR
Frankel F.1, Marchand B.1, Götte M.1, Wainberg M.A.1
1McGill University AIDS Centre, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada
|
|
12:40
WePp0103
Abstract
|
Binding energetics analysis shows a unique response of tipranavir to HIV-1 protease mutations associated with drug resistance
Muzammil S.1, Kang L.-W.2, Armstrong A.A.2, Jakalian A.3, Bonneau P.R.3, Schmelmer V.4, Amzel L.M.2, Freire E.1
1Department of Biology, Johns Hopkins University, Baltimore, MD, United States of America, 2Department of Biophysics and Biophysical Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD, United States of America, 3Boehringer Ingelheim (Canada) Ltd. Research & Development, Laval, Québec, Canada, 4Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, United States of America
|
|
12:45
WePp0104
Abstract
|
Multivalent compounds functionalized with the carbohydrate headgroups of immune cell-surface GSLs as inhibitors of HIV-1 infection.
Rosa Borges A.1, Puri A.2, Krebs F.C.3, Wigdahl B.3, Blumenthal R.2, Rawat S.S.2, Johnson B.T.2, Schengrund C.-L.1
1Penn State University, College of Medicine, Hershey, Pennsylvania, United States of America, 2Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America, 3Drexel University, College of Medicine, Philadelphia, Pennsylvania, United States of America
|
|
12:50
WePp0105
Abstract
|
Crystallographic study with BILR 355 BS, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) with a broad anti HIV-1 profile
Coulombe R.1, Fink D.1, Landry S.1, Lessard I.A.D.1, McCollum R.1, Naud J.1, O'Meara J.1, Simoneau B.1, Yoakim C.1, Bonneau P.R.1
1Boehringer Ingelheim (Canada) Ltd, Laval, Canada
|
|
12:55
WePp0106
Abstract
|
Novel compounds that inhibit HIV replication by acting through inhibition of HIV rev function
Rekosh D.1, Ptak R.2, Hammarskjold M.-L.1
1University of Virginia, Department of Microbiology, Charlottesville, VA, United States of America, 2Southern Research Institue, Department of Infectious Disease Research, Frederick, MD, United States of America
|
|
|